Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor
Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs,...
Saved in:
Published in | Stem cells translational medicine Vol. 9; no. 4; pp. 531 - 542 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.04.2020
Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 2157-6564 2157-6580 2157-6580 |
DOI | 10.1002/sctm.19-0199 |
Cover
Abstract | Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs.
Valproic acid (VPA)‐mediated ex vivo expansion of adult bone marrow and mobilized peripheral blood CD34+ cells resulted in a cellular product characterized by high viability, enrichment with CD34+CD45RA‐CD90+ cells, increased aldehyde dehydrogenase (ALDH) activity, robust multipotent clonogenic potential, and decreased mitochondrial potential. VPA‐expanded grafts were able to establish unbiased multilineage human hematopoietic‐cell chimerism in NSG mice at 16 weeks post‐transplantation. |
---|---|
AbstractList | Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs. Valproic acid (VPA)‐mediated ex vivo expansion of adult bone marrow and mobilized peripheral blood CD34+ cells resulted in a cellular product characterized by high viability, enrichment with CD34+CD45RA‐CD90+ cells, increased aldehyde dehydrogenase (ALDH) activity, robust multipotent clonogenic potential, and decreased mitochondrial potential. VPA‐expanded grafts were able to establish unbiased multilineage human hematopoietic‐cell chimerism in NSG mice at 16 weeks post‐transplantation. Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs. Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs.Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs. Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs. Valproic acid (VPA)‐mediated ex vivo expansion of adult bone marrow and mobilized peripheral blood CD34+ cells resulted in a cellular product characterized by high viability, enrichment with CD34+CD45RA‐CD90+ cells, increased aldehyde dehydrogenase (ALDH) activity, robust multipotent clonogenic potential, and decreased mitochondrial potential. VPA‐expanded grafts were able to establish unbiased multilineage human hematopoietic‐cell chimerism in NSG mice at 16 weeks post‐transplantation. Abstract Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs. |
Audience | Academic |
Author | Papa, Luena Patel, Ami Iancu‐Rubin, Camelia Djedaini, Mansour Zimran, Eran Hoffman, Ronald |
AuthorAffiliation | 1 Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York NY 2 Hematology Department Hadassah University Center Jerusalem Israel |
AuthorAffiliation_xml | – name: 2 Hematology Department Hadassah University Center Jerusalem Israel – name: 1 Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York NY |
Author_xml | – sequence: 1 givenname: Eran orcidid: 0000-0002-5483-5180 surname: Zimran fullname: Zimran, Eran email: eran.zimran@gmail.com organization: Hadassah University Center – sequence: 2 givenname: Luena surname: Papa fullname: Papa, Luena organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai – sequence: 3 givenname: Mansour surname: Djedaini fullname: Djedaini, Mansour organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai – sequence: 4 givenname: Ami surname: Patel fullname: Patel, Ami organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai – sequence: 5 givenname: Camelia surname: Iancu‐Rubin fullname: Iancu‐Rubin, Camelia organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai – sequence: 6 givenname: Ronald surname: Hoffman fullname: Hoffman, Ronald organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31950644$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk1v1DAQhiNUREvpjTOyxKUHUmwnseMLUrUqUKkSB8rZcuzJxqskXmxnt_sj-M843bLQSoAvtmcev_Pll9nR6EbIstcEXxCM6fug43BBRI6JEM-yE0oqnrOqxkeHMyuPs7MQVjgtJpig-EV2XBBRYVaWJ9mPq7u1GoN1I1KjQWsPAfxGxdngWhQ7QO006vmueqTSYWPjbnYpM_URdTCo6NbOQrQahQgD0tD3AenknTwYBHdoYzcObW3skEKdDTHVgAwoDXHXqwDIjp1tbHT-Vfa8VX2As4f9NPv28ep28Tm_-fLpenF5k-uqwiRv28oYqgrKddFyVgMRGkogmosKKCMcN40otDC0hIYzYXADylQcqGF1xUVxml3vdY1TK7n2dlB-J52y8t7g_FIqnwrqQTLDhKCaKt7wssRlUzQU2kqrFKKBukpa-V5rGtdqt1V9fxAkWM5TkvOUJBFynlLiP-z59dQMYDSM0av-URKPPaPt5NJtJCe4YGQWOH8Q8O77BCHKwYa56WoENwVJi5IwSoWoE_r2Cbpyk0-TnCmBKSY1J7-ppUoF27F1Ka6eReUlLziuBa1pot78mfch4V9_KQF0D2jvQvDQSm3j_U9Kcrb_WzfePXn0n-YVe3xre9j9k5VfF7cFoYyR4iez2P_m |
CitedBy_id | crossref_primary_10_1016_j_apsb_2021_12_006 crossref_primary_10_1097_MOH_0000000000000593 crossref_primary_10_1016_j_yexcr_2023_113599 crossref_primary_10_1016_j_jcyt_2021_04_001 crossref_primary_10_3390_epigenomes7040032 crossref_primary_10_1016_j_retram_2024_103444 crossref_primary_10_3390_ph14050423 crossref_primary_10_1182_bloodadvances_2024013047 crossref_primary_10_3390_cancers14071723 crossref_primary_10_1016_j_blre_2021_100853 crossref_primary_10_1016_j_exphem_2023_03_006 crossref_primary_10_1016_j_gde_2020_05_035 crossref_primary_10_1186_s13287_023_03370_z crossref_primary_10_1186_s43066_021_00165_w crossref_primary_10_1007_s40778_022_00209_w crossref_primary_10_3390_cells12060896 crossref_primary_10_1038_s41598_024_72386_z crossref_primary_10_1016_j_exphem_2022_08_004 crossref_primary_10_3389_fcell_2020_592348 crossref_primary_10_3390_ijms25021187 crossref_primary_10_1016_j_ymthe_2021_09_001 |
Cites_doi | 10.1097/MOH.0000000000000143 10.1016/j.bbmt.2013.12.562 10.1089/scd.2008.0235 10.1182/blood-2003-07-2431 10.1158/0008-5472.CAN-04-3063 10.1182/blood.V89.11.3919 10.1016/S0301-472X(01)00750-0 10.1016/j.stem.2010.07.011 10.1586/17474086.2016.1128321 10.1089/hgtb.2014.043 10.1002/sctm.17-0048 10.1038/sj.bmt.1704928 10.1016/j.stem.2007.10.001 10.1016/j.exphem.2016.04.007 10.1182/bloodadvances.2018024273 10.1182/blood.V96.10.3414 10.1182/blood.V128.22.818.818 10.1126/science.1191536 10.1016/j.jcyt.2012.10.014 10.1016/j.exphem.2009.05.012 10.1126/scitranslmed.aan1145 10.1182/blood-2004-02-0448 10.1182/blood-2006-07-035287 10.1016/j.tcb.2014.04.001 10.1089/hum.2019.009 10.1016/S0301-472X(02)00818-4 10.3324/haematol.2012.079244 10.1155/2019/4067162 10.1038/s41598-017-12360-0 10.1038/ncomms13125 10.1172/JCI70313 10.1089/hum.2016.107 10.1126/science.1201219 10.1016/j.stem.2012.01.006 10.1111/trf.12904 10.1089/scd.2011.0698 |
ContentType | Journal Article |
Copyright | 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. COPYRIGHT 2020 Oxford University Press 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press – notice: 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. – notice: COPYRIGHT 2020 Oxford University Press – notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION NPM 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
DOI | 10.1002/sctm.19-0199 |
DatabaseName | Wiley Online Library Open Access CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Ex vivo expansion of adult HSCs with valproic acid |
EISSN | 2157-6580 |
EndPage | 542 |
ExternalDocumentID | oai_doaj_org_article_6d6992c2a7b74404b3b2ef5cabb9be85 10.1002/sctm.19-0199 PMC7103619 A737089282 31950644 10_1002_sctm_19_0199 SCT312661 |
Genre | article Journal Article |
GeographicLocations | United States--US California |
GeographicLocations_xml | – name: United States--US – name: California |
GroupedDBID | 0R~ 1OC 24P 53G 5RE 7X7 8FE 8FH 8FI 8FJ AAHHS AAKDD AAPXW AAVAP ABEJV ABPTD ABUWG ABXVV ACCFJ ACCMX ACXQS ADBBV ADKYN ADZMN AEEZP AENEX AEQDE AFKRA AIWBW AJAOE AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMNDL AOIJS AVUZU BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU DIK EBD EBS EJD EMOBN FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE HZ~ LK8 M7P O9- OK1 OVD PIMPY PQQKQ PROAC RHI ROX RPM SV3 TOX UKHRP WIN AAMMB AAYXX ABGNP AEFGJ AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PQGLB PUEGO NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c5501-ff5dd2a327c3f768e19ce4e1c795e26170bb93c9d24eb769d0bead57e2d685793 |
IEDL.DBID | 7X7 |
ISSN | 2157-6564 2157-6580 |
IngestDate | Wed Aug 27 00:08:17 EDT 2025 Wed Aug 20 00:07:21 EDT 2025 Tue Sep 30 15:57:18 EDT 2025 Sun Aug 24 03:49:42 EDT 2025 Sat Sep 20 13:12:00 EDT 2025 Tue Jun 17 21:03:16 EDT 2025 Wed Feb 19 02:29:17 EST 2025 Thu Apr 24 22:56:12 EDT 2025 Wed Oct 01 04:33:24 EDT 2025 Wed Jan 22 16:34:34 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | adult bone marrow valproic acid hematopoietic stem cells mobilized peripheral blood ex vivo expansion histone deacetylase inhibitor |
Language | English |
License | Attribution-NonCommercial-NoDerivs http://creativecommons.org/licenses/by-nc-nd/4.0 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5501-ff5dd2a327c3f768e19ce4e1c795e26170bb93c9d24eb769d0bead57e2d685793 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5483-5180 |
OpenAccessLink | https://www.proquest.com/docview/2390201871?pq-origsite=%requestingapplication% |
PMID | 31950644 |
PQID | 2390201871 |
PQPubID | 4370291 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6d6992c2a7b74404b3b2ef5cabb9be85 unpaywall_primary_10_1002_sctm_19_0199 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7103619 proquest_miscellaneous_2341622998 proquest_journals_2390201871 gale_infotracmisc_A737089282 pubmed_primary_31950644 crossref_citationtrail_10_1002_sctm_19_0199 crossref_primary_10_1002_sctm_19_0199 wiley_primary_10_1002_sctm_19_0199_SCT312661 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2020 |
PublicationDateYYYYMMDD | 2020-04-01 |
PublicationDate_xml | – month: 04 year: 2020 text: April 2020 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Oxford |
PublicationTitle | Stem cells translational medicine |
PublicationTitleAlternate | Stem Cells Transl Med |
PublicationYear | 2020 |
Publisher | John Wiley & Sons, Inc Oxford University Press |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Oxford University Press |
References | 2017; 6 2017; 7 2011; 333 2004; 104 2010; 329 2002; 30 2019; 30 2016; 107 2015; 55 1997; 89 2014; 25 2014; 24 2005; 65 2016; 128 2017; 130 2001; 29 2007; 109 2012; 10 2017; 9 2014; 20 2016; 7 2013; 15 2018; 2 2013; 98 2000; 96 2015; 22 2019 2007; 1 2010; 7 2014; 103 2012; 21 2016; 9 2009; 37 2005; 35 2009; 18 2016; 44 2014; 124 Chaurasia (2022022809302389200_sct312661-bib-0008) 2014; 124 Romero-Moya (2022022809302389200_sct312661-bib-0017) 2013; 98 Majeti (2022022809302389200_sct312661-bib-0011) 2007; 1 Papa (2022022809302389200_sct312661-bib-0019) 2019 Rosler (2022022809302389200_sct312661-bib-0002) 2000; 96 De Felice (2022022809302389200_sct312661-bib-0031) 2005; 65 Radtke (2022022809302389200_sct312661-bib-0036) 2017; 9 Papa (2022022809302389200_sct312661-bib-0020) 2019 Boitano (2022022809302389200_sct312661-bib-0024) 2010; 329 Elizade (2022022809302389200_sct312661-bib-0034) 2012; 21 Tanavde (2022022809302389200_sct312661-bib-0003) 2002; 30 Saraf (2022022809302389200_sct312661-bib-0023) 2015; 55 Vannini (2022022809302389200_sct312661-bib-0016) 2016; 7 Simsek (2022022809302389200_sct312661-bib-0018) 2010; 7 Kohli (2022022809302389200_sct312661-bib-0015) 2014; 24 Araki (2022022809302389200_sct312661-bib-0030) 2009; 37 Psatha (2022022809302389200_sct312661-bib-0028) 2017; 6 Psatha (2022022809302389200_sct312661-bib-0006) 2016; 44 Yu (2022022809302389200_sct312661-bib-0007) 2016; 107 Dolatov (2022022809302389200_sct312661-bib-0001) 2012; 10 Arulmozhivarman (2022022809302389200_sct312661-bib-0035) 2017; 7 Araki (2022022809302389200_sct312661-bib-0029) 2007; 109 Carlin (2022022809302389200_sct312661-bib-0027) 2013; 15 Iancu-Rubin (2022022809302389200_sct312661-bib-0010) 2016; 128 Iancu-Rubin (2022022809302389200_sct312661-bib-0009) 2015; 22 Hess (2022022809302389200_sct312661-bib-0013) 2004; 104 Danet (2022022809302389200_sct312661-bib-0037) 2001; 29 Mahmud (2022022809302389200_sct312661-bib-0033) 2014; 20 Baron (2022022809302389200_sct312661-bib-0005) 2016; 9 Moussy (2022022809302389200_sct312661-bib-0038) 2019; 30 Milhem (2022022809302389200_sct312661-bib-0022) 2014; 103 Papa (2022022809302389200_sct312661-bib-0021) 2018; 2 Hoban (2022022809302389200_sct312661-bib-0025) 2017; 130 Gul (2022022809302389200_sct312661-bib-0032) 2009; 18 Lioznov (2022022809302389200_sct312661-bib-0014) 2005; 35 Wang (2022022809302389200_sct312661-bib-0004) 1997; 89 Gu (2022022809302389200_sct312661-bib-0026) 2014; 25 Notta (2022022809302389200_sct312661-bib-0012) 2011; 333 |
References_xml | – volume: 30 start-page: 1023 issue: 8 year: 2019 end-page: 1034 article-title: Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid publication-title: Hum Gene Ther – volume: 89 start-page: 3919 issue: 11 year: 1997 end-page: 3924 article-title: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID‐repopulating assay publication-title: Blood – volume: 22 start-page: 279 year: 2015 end-page: 285 article-title: Role of epigenetic reprogramming in hematopoietic stem cell function publication-title: Curr Opin Hematol – volume: 107 start-page: 729 year: 2016 end-page: 740 article-title: Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles publication-title: Human Gene Ther – volume: 29 start-page: 1465 year: 2001 end-page: 1473 article-title: Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion publication-title: Exp Hematol – volume: 18 start-page: 831 issue: 6 year: 2009 end-page: 838 article-title: Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling publication-title: Stem Cells Dev – volume: 10 start-page: 120 issue: 2 year: 2012 end-page: 137 article-title: Hematopoiesis: a human perspective publication-title: Cell Stem Cell – volume: 130 start-page: 3341 year: 2017 article-title: Aryl hydrocarbon receptor antagonists expand adult hematopoietic stem cells from mobilized peripheral blood and bone marrow and increase the dose of CRISPR/Cas9 gene‐edited NSG‐repopulating cells publication-title: Blood – volume: 15 start-page: 224 issue: 2 year: 2013 end-page: 230 article-title: T‐cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists publication-title: Cytotherapy – volume: 104 start-page: 1648 issue: 6 year: 2004 end-page: 1655 article-title: Functional characterization of highly purified human hematopoietic human repopulating cells isolated according to aldehyde dehydrogenase activity publication-title: Blood – volume: 35 start-page: 909 issue: 9 year: 2005 end-page: 914 article-title: Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants publication-title: Bone Marrow Transplant – volume: 329 start-page: 1345 year: 2010 end-page: 1348 article-title: Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells publication-title: Science – volume: 103 start-page: 4102 issue: 11 year: 2014 end-page: 4110 article-title: Modification of hematopoietic stem cell fate by 5aza2'deoxycytidine and trichostatin A publication-title: Blood – volume: 44 start-page: 528 year: 2016 end-page: 539 article-title: Optimizing autologous cell grafts to improve stem cell gene therapy publication-title: Exp Hematol – volume: 7 year: 2016 article-title: Specification of haematopoieitc stem cell fate via modulation of mitochondrial activity publication-title: Nat Commun – volume: 124 start-page: 2378 issue: 6 year: 2014 end-page: 2395 article-title: Epigenetic reprogramming induces the expansion of cord blood stem cells publication-title: J Clin Invest – volume: 7 start-page: 380 issue: 3 year: 2010 end-page: 390 article-title: The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche publication-title: Cell Stem Cell – volume: 9 start-page: 1 issue: 414 year: 2017 end-page: 10 article-title: A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates publication-title: Sci Trans Med – volume: 96 start-page: 3414 issue: 10 year: 2000 end-page: 3421 article-title: An in vivo competitive repopulation assay for various sources of human hematopoitic stem cells publication-title: Blood – volume: 25 start-page: 221 issue: 4 year: 2014 end-page: 231 article-title: Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short‐term culture in the presencce of an aryl hydrocarbon receptor antagonist publication-title: Hum Gene Ther Methods – volume: 37 start-page: 1084 year: 2009 end-page: 1095 article-title: Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues publication-title: Exp Hematol – volume: 333 start-page: 218 year: 2011 end-page: 221 article-title: Isolation of single human hematopoietic stem cells capable of long‐term multiliniage engraftment publication-title: Science – year: 2019 article-title: Mitochondrial role in stemness and differentiation of hematopoietic stem cells publication-title: Stem Cells Int – volume: 21 start-page: 2581 issue: 4 year: 2012 end-page: 2591 article-title: Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells publication-title: Stem Cells Dev – volume: 30 start-page: 816 year: 2002 end-page: 823 article-title: Human stem‐progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood publication-title: Exp Hematol – year: 2019 article-title: Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis publication-title: Ann N Y Acad Sci – volume: 128 start-page: 818 year: 2016 article-title: Preclinical development of a cord blood (CB)‐derived hematopoietic stem cell (HSC) product for allogeneic transplantation in patients with hematological malignancies publication-title: Blood – volume: 9 start-page: 297 issue: 3 year: 2016 end-page: 314 article-title: Methods of expansion of human cord blood cells: challenges, successes and clinical implications publication-title: Exp Rev Hematol – volume: 2 start-page: 2766 issue: 20 year: 2018 end-page: 2779 article-title: Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation publication-title: Blood Adv – volume: 55 start-page: 864 year: 2015 end-page: 874 article-title: Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers publication-title: Transfusion – volume: 109 start-page: 3570 issue: 8 year: 2007 end-page: 3578 article-title: Chromatin‐modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential publication-title: Blood – volume: 20 start-page: 480 year: 2014 end-page: 489 article-title: Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells publication-title: Biol Blood Marrow Transplant – volume: 98 start-page: 1022 issue: 7 year: 2013 end-page: 1029 article-title: Cord blood‐derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function publication-title: Haematologica – volume: 1 start-page: 635 year: 2007 end-page: 645 article-title: Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood publication-title: Cell Stem Cell – volume: 6 start-page: 1852 issue: 10 year: 2017 end-page: 1858 article-title: Brief report: a differential transcriptomic profile of ex vivo expanded adult human hematopoietic stem cells empowers them for engraftment better than their surface phenotype publication-title: Stem Cell Trans – volume: 24 start-page: 479 issue: 8 year: 2014 end-page: 487 article-title: Surviving change: the metabolic journey of hematopoietic stem cells publication-title: Trends Cell Biol – volume: 65 start-page: 1505 issue: 4 year: 2005 end-page: 1513 article-title: Histone deacetylase inhibitor valproic acid enhances the cytokine‐induced expansion of human hematopoietic stem cells publication-title: Cancer Res – volume: 7 issue: 1 year: 2017 article-title: Zebrafish in‐vivo screening for compounds amplifying hematopoietic stem and progenitor cells: preclinical validation in human CD34+ stem and progenitor cells publication-title: Sci Rep – volume: 22 start-page: 279 year: 2015 ident: 2022022809302389200_sct312661-bib-0009 article-title: Role of epigenetic reprogramming in hematopoietic stem cell function publication-title: Curr Opin Hematol doi: 10.1097/MOH.0000000000000143 – volume: 20 start-page: 480 year: 2014 ident: 2022022809302389200_sct312661-bib-0033 article-title: Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2013.12.562 – volume: 18 start-page: 831 issue: 6 year: 2009 ident: 2022022809302389200_sct312661-bib-0032 article-title: Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling publication-title: Stem Cells Dev doi: 10.1089/scd.2008.0235 – volume: 103 start-page: 4102 issue: 11 year: 2014 ident: 2022022809302389200_sct312661-bib-0022 article-title: Modification of hematopoietic stem cell fate by 5aza2’deoxycytidine and trichostatin A publication-title: Blood doi: 10.1182/blood-2003-07-2431 – volume: 65 start-page: 1505 issue: 4 year: 2005 ident: 2022022809302389200_sct312661-bib-0031 article-title: Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-3063 – volume: 89 start-page: 3919 issue: 11 year: 1997 ident: 2022022809302389200_sct312661-bib-0004 article-title: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating assay publication-title: Blood doi: 10.1182/blood.V89.11.3919 – volume: 29 start-page: 1465 year: 2001 ident: 2022022809302389200_sct312661-bib-0037 article-title: Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion publication-title: Exp Hematol doi: 10.1016/S0301-472X(01)00750-0 – volume: 7 start-page: 380 issue: 3 year: 2010 ident: 2022022809302389200_sct312661-bib-0018 article-title: The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche publication-title: Cell Stem Cell doi: 10.1016/j.stem.2010.07.011 – volume: 9 start-page: 297 issue: 3 year: 2016 ident: 2022022809302389200_sct312661-bib-0005 article-title: Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications publication-title: Exp Rev Hematol doi: 10.1586/17474086.2016.1128321 – volume: 25 start-page: 221 issue: 4 year: 2014 ident: 2022022809302389200_sct312661-bib-0026 article-title: Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presencce of an aryl hydrocarbon receptor antagonist publication-title: Hum Gene Ther Methods doi: 10.1089/hgtb.2014.043 – volume: 6 start-page: 1852 issue: 10 year: 2017 ident: 2022022809302389200_sct312661-bib-0028 article-title: Brief report: a differential transcriptomic profile of ex vivo expanded adult human hematopoietic stem cells empowers them for engraftment better than their surface phenotype publication-title: Stem Cell Trans doi: 10.1002/sctm.17-0048 – volume: 35 start-page: 909 issue: 9 year: 2005 ident: 2022022809302389200_sct312661-bib-0014 article-title: Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1704928 – volume: 1 start-page: 635 year: 2007 ident: 2022022809302389200_sct312661-bib-0011 article-title: Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.10.001 – volume: 44 start-page: 528 year: 2016 ident: 2022022809302389200_sct312661-bib-0006 article-title: Optimizing autologous cell grafts to improve stem cell gene therapy publication-title: Exp Hematol doi: 10.1016/j.exphem.2016.04.007 – volume: 2 start-page: 2766 issue: 20 year: 2018 ident: 2022022809302389200_sct312661-bib-0021 article-title: Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation publication-title: Blood Adv doi: 10.1182/bloodadvances.2018024273 – volume: 96 start-page: 3414 issue: 10 year: 2000 ident: 2022022809302389200_sct312661-bib-0002 article-title: An in vivo competitive repopulation assay for various sources of human hematopoitic stem cells publication-title: Blood doi: 10.1182/blood.V96.10.3414 – volume: 128 start-page: 818 year: 2016 ident: 2022022809302389200_sct312661-bib-0010 article-title: Preclinical development of a cord blood (CB)-derived hematopoietic stem cell (HSC) product for allogeneic transplantation in patients with hematological malignancies publication-title: Blood doi: 10.1182/blood.V128.22.818.818 – volume: 329 start-page: 1345 year: 2010 ident: 2022022809302389200_sct312661-bib-0024 article-title: Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells publication-title: Science doi: 10.1126/science.1191536 – volume: 15 start-page: 224 issue: 2 year: 2013 ident: 2022022809302389200_sct312661-bib-0027 article-title: T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists publication-title: Cytotherapy doi: 10.1016/j.jcyt.2012.10.014 – volume: 37 start-page: 1084 year: 2009 ident: 2022022809302389200_sct312661-bib-0030 article-title: Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues publication-title: Exp Hematol doi: 10.1016/j.exphem.2009.05.012 – volume: 9 start-page: 1 issue: 414 year: 2017 ident: 2022022809302389200_sct312661-bib-0036 article-title: A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates publication-title: Sci Trans Med doi: 10.1126/scitranslmed.aan1145 – volume: 104 start-page: 1648 issue: 6 year: 2004 ident: 2022022809302389200_sct312661-bib-0013 article-title: Functional characterization of highly purified human hematopoietic human repopulating cells isolated according to aldehyde dehydrogenase activity publication-title: Blood doi: 10.1182/blood-2004-02-0448 – volume: 109 start-page: 3570 issue: 8 year: 2007 ident: 2022022809302389200_sct312661-bib-0029 article-title: Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential publication-title: Blood doi: 10.1182/blood-2006-07-035287 – volume: 24 start-page: 479 issue: 8 year: 2014 ident: 2022022809302389200_sct312661-bib-0015 article-title: Surviving change: the metabolic journey of hematopoietic stem cells publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2014.04.001 – volume: 30 start-page: 1023 issue: 8 year: 2019 ident: 2022022809302389200_sct312661-bib-0038 article-title: Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid publication-title: Hum Gene Ther doi: 10.1089/hum.2019.009 – volume: 30 start-page: 816 year: 2002 ident: 2022022809302389200_sct312661-bib-0003 article-title: Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood publication-title: Exp Hematol doi: 10.1016/S0301-472X(02)00818-4 – volume: 98 start-page: 1022 issue: 7 year: 2013 ident: 2022022809302389200_sct312661-bib-0017 article-title: Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function publication-title: Haematologica doi: 10.3324/haematol.2012.079244 – year: 2019 ident: 2022022809302389200_sct312661-bib-0019 article-title: Mitochondrial role in stemness and differentiation of hematopoietic stem cells publication-title: Stem Cells Int doi: 10.1155/2019/4067162 – volume: 7 issue: 1 year: 2017 ident: 2022022809302389200_sct312661-bib-0035 article-title: Zebrafish in-vivo screening for compounds amplifying hematopoietic stem and progenitor cells: preclinical validation in human CD34+ stem and progenitor cells publication-title: Sci Rep doi: 10.1038/s41598-017-12360-0 – volume: 7 year: 2016 ident: 2022022809302389200_sct312661-bib-0016 article-title: Specification of haematopoieitc stem cell fate via modulation of mitochondrial activity publication-title: Nat Commun doi: 10.1038/ncomms13125 – volume: 124 start-page: 2378 issue: 6 year: 2014 ident: 2022022809302389200_sct312661-bib-0008 article-title: Epigenetic reprogramming induces the expansion of cord blood stem cells publication-title: J Clin Invest doi: 10.1172/JCI70313 – volume: 107 start-page: 729 year: 2016 ident: 2022022809302389200_sct312661-bib-0007 article-title: Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles publication-title: Human Gene Ther doi: 10.1089/hum.2016.107 – volume: 333 start-page: 218 year: 2011 ident: 2022022809302389200_sct312661-bib-0012 article-title: Isolation of single human hematopoietic stem cells capable of long-term multiliniage engraftment publication-title: Science doi: 10.1126/science.1201219 – volume: 10 start-page: 120 issue: 2 year: 2012 ident: 2022022809302389200_sct312661-bib-0001 article-title: Hematopoiesis: a human perspective publication-title: Cell Stem Cell doi: 10.1016/j.stem.2012.01.006 – year: 2019 ident: 2022022809302389200_sct312661-bib-0020 article-title: Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis publication-title: Ann N Y Acad Sci – volume: 55 start-page: 864 year: 2015 ident: 2022022809302389200_sct312661-bib-0023 article-title: Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers publication-title: Transfusion doi: 10.1111/trf.12904 – volume: 21 start-page: 2581 issue: 4 year: 2012 ident: 2022022809302389200_sct312661-bib-0034 article-title: Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells publication-title: Stem Cells Dev doi: 10.1089/scd.2011.0698 – volume: 130 start-page: 3341 year: 2017 ident: 2022022809302389200_sct312661-bib-0025 article-title: Aryl hydrocarbon receptor antagonists expand adult hematopoietic stem cells from mobilized peripheral blood and bone marrow and increase the dose of CRISPR/Cas9 gene-edited NSG-repopulating cells publication-title: Blood |
SSID | ssj0000696920 |
Score | 2.3264675 |
Snippet | Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to... Abstract Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their... |
SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 531 |
SubjectTerms | adult bone marrow Aldehyde dehydrogenase Blood Bone marrow CD34 antigen CD45RA antigen CD90 antigen Cord blood Cytokines Divalproex Ethylenediaminetetraacetic acid ex vivo expansion Expansion Experiments Flow cytometry Genetically modified organisms Granulocytes Hematology Hematopoietic stem cells Histone deacetylase histone deacetylase inhibitor Kinases Laboratories Ligands Lymphocytes T Membrane potential Mitochondria mobilized peripheral blood Ontology Peripheral blood Stem cell transplantation Stem cells T cells Tissue‐specific Progenitor and Stem Cells Umbilical cord Valproic acid |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJQQXxDeBgowEXCB0YydxfCxVqwoJLrRSb5btTNRI22TV3S3dH8F_ZsbOhl0Q9MI1dnZjz3jmzWj8hrE3E3Bl4XyVKkD4lgtXpZWkEiirGyWFLapQVfnla3l8mn8-K842Wn1RTVikB44bt1fWpdbCC6tc4LJz0gloCm-d0w6qwF6KbmwjmIo2WJc6cDKiS1MpgpZ8qHpHC7A394uLj3R5J1K-_vJHgbb_T-O84Z1-r5y8s-xmdvXdTqfb6Da4p6P77N6AK_l-XM8Ddgu6h-x27DS5esR-HF7jsafMGLddzan6dZ2N5X3DEQVy8nAxMcjpsgP1lKChQNDBA7VrP-tbuvPIifyZU8p_ziNzB9QcrvlVe9VzSuxyywOPcQe8RpMLixVidOBtd946tCCXj9np0eHJwXE6dGJIPUYwWdo0RV0LK4XyssEABTLtIYfMK11A4HRHaUiva5GDU6WuJw41tFAg6rIq0AQ8YTsd_ukzxnMJqsrx10piNsu08_gAzQAIhEauqRL2fi0P4weacuqWMTWRYFkYkp7JtCHpJeztOHsW6Tn-Mu8TiXacQ6Ta4QGqmhlUzdykagnbJcUwdPTxkzweRG_2lVSTSmPkisNrhTGDIZgbITUC8gzD0oS9HofpTSpu66Bf0hxExQJxAS7-adSv8UMltelFzJowtaV5WyvZHuna80ATjthR4gYn7N2oozfs0YegwP-cZL4dnMiMUN3z_7GlL9hdQQmMUAq1y3YWl0t4iShv4V6FA_0THblQJA priority: 102 providerName: Directory of Open Access Journals – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdGJ8Re-GYEBjIS8AIpjZ3E8WOZNk1ITEi00niyYsdhFSWp2nSs_A_8z9w5H5AiPh54i2InsU_n8-8u598R8nRkdRxpk_jCAnwLmU78hGMKVCpzwVkaJS6r8u1pfDIN35xFZztk0p6FQfZiDFmvGlGuhjVjRBeCw7XiLDgu-UWW15a_-d_PXq1M9XmI53ICKa-Q3Rh_Ow3I7vT03fgD1pkLIuEDhAl_XCejJh9--_HeTuUI_X812z_tW9s5ldfWxSLdfEnn8z7udRvX8Q2ybqdc56t8Gq4rPTRft9gg_7dMbpLrDdKl41o1b5EdW9wmV-val5s75NvRJRgijNXRtMgo5uO28WFa5hRwKcU9tw5VUjx-gVUusMlRhlBHNlsuyhmewqQ4eOpGT2suEZtRe0kvZhclxVAzTaljVi4szWATsNUGvAZLZ8X5TINNW94l0-OjyeGJ39SG8A34VIGf51GWsZQzYXgOLpMNpLGhDYyQkXUs81pLbmTGQqtFLLORhjUTCcuyOInAKN0jgwI-ep_QkFuRhPC2GLnWAqkN3ADDZBmANZ0nHnnR6oEyDXE61u-Yq5rymSkUsAqkQgF75FnXe1EThvym32tUqa4P0ny7G-Xyo2qshoqzWEpmWCq0I3LUXDObRyaFyWmbRB45QIVUaIxgSAZMg1FjwcUokeBLQ3OrqKrVHcW4BBchAEfZI0-6ZnwS0-0KW66xD-B0BkgFJr9f63U3UI6FgwFFe0T0NL43k35LMTt3xOWAZjkI2CPPu7XxFxm9dLr9x07q_eGEB4gzH_zrex-SPYZhE5eAdUAG1XJtHwG2rPTjxlR8B-6QfHk priority: 102 providerName: Unpaywall – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagHOCCingFCjIScIHQjZ3E8bFUrSokEBKt1JtlOxMaaUlW--jjR_Q_d8bJpk0RIK7xxInteXwejT8z9nYCLs-cL2IFCN9S4Yq4kFQCZXWlpLBZEaoqv37LD47SL8fZcZ9wo7MwHT_EkHAjywj-mgzcusX2NWnowi9_faITOInWd9m9hAI_MTun34ccyyTXuQ7MjBjYVIzQJe1r37GL7ZsdjKJSIO__3UXfiFG36yfvr5qZvTiz0-kY44Ygtb_JHvboku906vCI3YHmMbvcO0eTp6wYt03JqfJ1nYnlbcURAXKKbl1SkNNBB7pPgpoCOQcPtK7trK3pvCMn4mdO6f4F71g7oORwzk_r05ZTUpdbHjiMG-AlultYXiA-B143J7VD7zF_wo729w53D-L-FobY4-4liasqK0thpVBeVrg5gUR7SCHxSmcQ-Nyd09LrUqTgVK7LiUPtzBSIMi8yNP-nbKPBjz5nPJWgihR7y4nVLNHO4wN0ASAQFrmqiNiH9SoY31OU000ZU9ORKwtDa2YSbWjNIvZukJ511Bx_kPtMCzrIEKF2eNDOf5rePk1e5loLL6xygTLRSSegyrzFwTkosohtkToYMnv8JY9G6M2OkmpSaNy1YvNaTUzvBBZGSI1gPMEtacTeDM30JhW2NdCuSAYRsUBMgIN_1mnV8KOSruhFvBoxNdK30UjGLU19EijCETdKnOCIvR808x9z9DGo7V-FzI_dQ5kQonvxf-Iv2QNBaYpQ8LTFNpbzFbxCLLd0r4PBXgGwHkYW priority: 102 providerName: Wiley-Blackwell |
Title | Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsctm.19-0199 https://www.ncbi.nlm.nih.gov/pubmed/31950644 https://www.proquest.com/docview/2390201871 https://www.proquest.com/docview/2341622998 https://pubmed.ncbi.nlm.nih.gov/PMC7103619 https://stemcellsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sctm.19-0199 https://doaj.org/article/6d6992c2a7b74404b3b2ef5cabb9be85 |
UnpaywallVersion | publishedVersion |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2157-6580 dateEnd: 20211231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2157-6580 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: DIK dateStart: 20120101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2157-6580 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 2157-6580 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: TOX dateStart: 20120101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2157-6580 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: 7X7 dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2157-6580 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: BENPR dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 2157-6580 dateEnd: 20211231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: AVUZU dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2157-6580 dateEnd: 20211231 omitProxy: true ssIdentifier: ssj0000696920 issn: 2157-6564 databaseCode: 24P dateStart: 20120101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLbYJsReEHcCozIS8AJhjZ3E8RPqpk4TElUFq1SerPgSVqlLSi9j_RH8Z85x0oyCGI-NT9s4Pj7-_OX4O4S86jqdJtpkoXAA32KmszDjmAKVy0JwlieZz6r8NEhPR_HHcTJuCLdFk1a5iYk-UNvKIEd-yGBzzrCCXPRh9j3EqlH4drUpobFD9iKAKujVYixajqWbylR6ZUZY2EQI0CVuct8hDhwuzPLiPR7hqYVfr1clL97_d4j-bY36M3_yzqqc5esf-XS6jXH9InVyj9xt0CXt1e5wn9xy5QNyu643uX5IfvavYPIjP0bz0lLMgd1wsrQqKGBBiutcTQ9SPPKAlSWwyct0UC_wWs2qCZ58pCgBTZH4X9Bav8NZ6q7o5eSyokjv0px6NePSUQuB1y3XgNQdnZTnEw1xZP6IjE76Z8enYVOPITSwj4nCokisZTlnwvACtikuksbFLjJCJs4ru2stuZGWxU6LVNquBj9NhGM2zRIIBI_Jbgl_-pTQmDuRxfBrKeqbRVIbuADBwDEASLrIAvJ2Mx7KNGLlWDNjqmqZZaZw9FQkFY5eQF631rNapOMfdkc4tK0NSmv7C9X8m2pmqkptKiUzLBfaiydqrpkrEpND57TLkoAcoGMoDABwSwamo1E9wUU3k7B_heaNw6gmHCzUtfMG5GXbjN_EFLfSVSu0AWzMAB1A55_U_tXeKMdivYBcAyK2PG-rJ9st5eTci4UDguTwgAPypvXR_zyjd96BbzRSX47PeITY7tnN3X1O9hkSFD7V6YDsLucr9wJQ3FJ3yA6Lhx0_YTtk76g_GH7ueEYEPo0Gw97XX3FLS80 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlQuiDeBAkaiXCA0sZM4PiBUSqstfVzYSntzY8ehKy3Jso-2-yP4K_xGZpxHWRDl1Gvs7MaeyefPk_E3hLwKrE5ibVJfWKBvEdOpn3JMgcpkITjL4tRlVR4eJb3j6PMgHqyQn-1ZGEyrbDHRAXVeGYyRbzLYnDOsIBd-GH_3sWoUfl1tS2jUbrFvF-ewZZu-3_sE9t1gbHenv93zm6oCvgE2HvpFEec5yzgThhdAtm0ojY1saISMrdMn11pyI3MWWS0SmQcaZjsWluVJGgsUXwLIvxHxIEKtfjEQXUwnSGQinRIkLKTCB6oUNbn2gDubUzP79g6PDNVCs5eroCsW8PeS8Nua-Ge-5tq8HGeL82w0WubUblHcvUNuN2yWbtXud5es2PIeuVnXt1zcJz92LgBsMB5HszKnmHPbxoBpVVDgnhTX1TocSfGIBVaywCYnC0KdoGw1roZ40pKi5DTFDw1TWuuF2JzaC3o2PKsohpNpRp16cmlpDkBvZwvYGVg6LE-HGnBr8oAcX4ulHpLVEv70MaERtyKN4NcS1FMLpTZwAcDHMiBkukg98qa1hzKNODrW6BipWtaZKbSeCqVC63lko-s9rkVB_tHvI5q264NS3u5CNfmqGmRQSZ5IyQzLhHZijZprZovYZDA4bdPYI-voGAoBBx7JwOtv1JbgIkgl7JehuXUY1cDPVF2-LB552TXjnZhSV9pqjn2AizNgIzD4R7V_dQ_KsTgwMGWPiCXPWxrJcks5PHXi5MBYOUywR153PvqfOXrrHPjKTurLdp-HyCWfXD3cF2St1z88UAd7R_tPyS2GwRGXZrVOVmeTuX0GDHKmn7vXlpKT68aJX6Iug80 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELWqIi4viDuBAkaivEDYjZ3E8QNCpe2qpVAh0Ur75saOQyMtybKXtvsR_BBfx4xzKQuiPPU1dnZjz-T4eDI-Q8iLvtVxpE3iCwv0LWQ68ROOKVCpzAVnaZS4rMpP-_HOYfhhGA1XyM_2LAymVbaY6IA6qwzGyHsMNucMK8gFvbxJi_i8NXg3_u5jBSn80tqW06hdZM8uTmH7Nn27uwW2XmdssH2wueM3FQZ8A8w88PM8yjKWciYMz4F420AaG9rACBlZp1WuteRGZiy0WsQy62uY-UhYlsVJJFCICeD_iuAhx3QyMRRdfKcfy1g6VUhYVIUPtCls8u4Bg3pTM_v2Bo8P1aKz5yuiKxzw9_Lw2_r4Z-7m9Xk5Then6Wi0zK_dAjm4RW42zJZu1K54m6zY8g65Wte6XNwlP7bPAHgwNkfTMqOYf9vGg2mVU-ChFNfYOjRJ8bgFVrXAJicRQp24bDWuCjx1SVF-muJHhymttUNsRu0ZPSlOKoqhZZpSp6RcWpoB6NvZAnYJlhblcaEBwyb3yOGlWOo-WS3hTx8SGnIrkhB-LUZttUBqAxcAiCwDcqbzxCOvWnso0wilY72OkaolnplC66lAKrSeR9a73uNaIOQf_d6jabs-KOvtLlSTr6pBCRVnsZTMsFRoJ9youWY2j0wKg9M2iTyyho6hEHzgkQxAgVEbgot-ImHvDM2tw6gGiqbq_MXxyPOuGe_E9LrSVnPsA7ycATOBwT-o_at7UI6FgoE1e0Qsed7SSJZbyuLYCZUDe-UwwR552fnof-botXPgCzupL5sHPEBe-eji4T4j1wAh1Mfd_b3H5AbDOInLuFojq7PJ3D4BMjnTT91bS8nRZcPEL9rhiAg |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdGJ8Re-GYEBjIS8AIpjZ3E8WOZNk1ITEi00niyYsdhFSWp2nSs_A_8z9w5H5AiPh54i2InsU_n8-8u598R8nRkdRxpk_jCAnwLmU78hGMKVCpzwVkaJS6r8u1pfDIN35xFZztk0p6FQfZiDFmvGlGuhjVjRBeCw7XiLDgu-UWW15a_-d_PXq1M9XmI53ICKa-Q3Rh_Ow3I7vT03fgD1pkLIuEDhAl_XCejJh9--_HeTuUI_X812z_tW9s5ldfWxSLdfEnn8z7udRvX8Q2ybqdc56t8Gq4rPTRft9gg_7dMbpLrDdKl41o1b5EdW9wmV-val5s75NvRJRgijNXRtMgo5uO28WFa5hRwKcU9tw5VUjx-gVUusMlRhlBHNlsuyhmewqQ4eOpGT2suEZtRe0kvZhclxVAzTaljVi4szWATsNUGvAZLZ8X5TINNW94l0-OjyeGJ39SG8A34VIGf51GWsZQzYXgOLpMNpLGhDYyQkXUs81pLbmTGQqtFLLORhjUTCcuyOInAKN0jgwI-ep_QkFuRhPC2GLnWAqkN3ADDZBmANZ0nHnnR6oEyDXE61u-Yq5rymSkUsAqkQgF75FnXe1EThvym32tUqa4P0ny7G-Xyo2qshoqzWEpmWCq0I3LUXDObRyaFyWmbRB45QIVUaIxgSAZMg1FjwcUokeBLQ3OrqKrVHcW4BBchAEfZI0-6ZnwS0-0KW66xD-B0BkgFJr9f63U3UI6FgwFFe0T0NL43k35LMTt3xOWAZjkI2CPPu7XxFxm9dLr9x07q_eGEB4gzH_zrex-SPYZhE5eAdUAG1XJtHwG2rPTjxlR8B-6QfHk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expansion+and+preservation+of+the+functional+activity+of+adult+hematopoietic+stem+cells+cultured+ex+vivo+with+a+histone+deacetylase+inhibitor&rft.jtitle=Stem+cells+translational+medicine&rft.au=Zimran%2C+Eran&rft.au=Papa%2C+Luena&rft.au=Djedaini%2C+Mansour&rft.au=Patel%2C+Ami&rft.date=2020-04-01&rft.eissn=2157-6580&rft.volume=9&rft.issue=4&rft.spage=531&rft_id=info:doi/10.1002%2Fsctm.19-0199&rft_id=info%3Apmid%2F31950644&rft.externalDocID=31950644 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-6564&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-6564&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-6564&client=summon |